Rylo Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: shoppers who want the pharmacy and medical group named before they buy
Rylo Health is one of the most affordable GLP-1 options on the market.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Texas-prescriber telehealth selling compounded semaglutide and tirzepatide alongside a peptide line, naming both its medical group and its dispensing pharmacy.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rylo Health
RNK Health
Best for: compounded GLP-1 alongside NAD+, peptide and longevity add-ons
Editorial score · methodology
Wellorithm
Best for: compounded GLP-1 access with oral tablet options across 49 states
Editorial score · methodology
Editorial score · methodology
Rylo Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo (Standard rate $149/mo; quarterly $349. A First 20 promotional rate of $100/mo is advertised for the first 20 patients.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Rylo Health
Each dimension is scored algorithmically from Rylo Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.5/10At $149/mo, Rylo Health runs about 12% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.1/10Rylo Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 4 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-30).
Accessibility10%
8.3/10Rylo Health treats patients in all 50 states.
Support10%
5.9/10Rylo Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rylo Health review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Rylo Health
We walked Rylo Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Homepage lists every protocol with its price, promotional and standard, before any intake
- 2Get Started leads to a stated three-step flow: questionnaire, same-day provider review, delivery
- 3Site states five minutes to complete and free monthly shipping
- 4A valid prescription is required and eligibility is decided by the provider
- Walked the public funnel only: no account was created, no health information was submitted and no payment step was reached
- Unusually transparent on supply chain. The FAQ names the pharmacy outright: VialsRX, 6220 Westpark Dr, Houston, TX 77057, with a phone number and vials.ai
- VialsRX is the same Houston pharmacy that Voxy names, which is a supply-chain overlap worth tracking
- Both the promotional First 20 price and the standard price are shown side by side, which is rare and makes the real ongoing cost obvious
- Cancellation is advertised as one click with no retention call, and the FAQ repeats no contracts and no cancellation fees
- Several peptides are listed as coming soon, so the live catalogue is smaller than the menu suggests
Rylo Health customer support
GLP-1 medications Rylo Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Rylo Health offers
Beyond GLP-1s, Rylo Health also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Standard rate $149/mo; quarterly $349. A First 20 promotional rate of $100/mo is advertised for the first 20 patients.
Standard rate $249/mo; quarterly $499. A First 20 promotional rate of $160/mo is advertised for the first 20 patients.
Ready to get started?
Plans and promotions change often — check Rylo Health's current pricing and active discounts before you decide.
What we like
- Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
- Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
- Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
- Cancel in one click from the patient portal, with no contracts and no cancellation fees
- Peptide line priced openly, including NAD+ and sermorelin
Watch-outs
- Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
- No LegitScript certification is claimed or displayed
- Several peptide products are advertised as coming soon rather than available
- No published refund policy beyond the no-cancellation-fee statement
Is Rylo Health worth it? Our verdict
Rylo Health positions itself around one thing: shoppers who want the pharmacy and medical group named before they buy. It runs $149/month, flat across every dose — toward the affordable end of the market. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Rylo Health rounds out its offering with Named Pharmacy.
How much Rylo Health actually costs
- Compounded semaglutide — $149/month
- Compounded tirzepatide — $249/month
That puts Rylo Health below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Found (about $149/month) is one of the closest alternatives to weigh Rylo Health against.
Medications: what Rylo Health prescribes
Rylo Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Rylo Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Rylo Health treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rylo Health earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Rylo Health is one of the most affordable GLP-1 options on the market.
Ready to start with Rylo Health?
Starting at $149/month. See current pricing and start your free consultation.
Rylo Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider RNK Health.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rylo Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rylo Health's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.